Osmoregulation Performance and Kidney Transplant Outcome.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
07 2019
Historique:
received: 27 12 2018
accepted: 29 03 2019
pubmed: 21 6 2019
medline: 21 4 2020
entrez: 21 6 2019
Statut: ppublish

Résumé

Kidney transplant recipients have an impaired ability to dilute urine but seldom develop baseline hyponatremia before ESRD. Although hyponatremia is a risk factor for adverse events in CKD and in kidney transplant recipients, it remains unclear whether subtler alterations in osmoregulation performance are associated with outcome. We studied a single-center prospective cohort of 1258 kidney transplant recipients who underwent a water-loading test 3 months after transplant to determine osmoregulation performance. Measured GFR (mGFR) was performed at the same visit. A group of 164 healthy candidates for kidney donation served as controls. We further evaluated the association of osmoregulation performance with transplantation outcomes and subsequent kidney function. Unlike controls, most kidney transplant recipients failed to maintain plasma sodium during water loading (plasma sodium slope of -0.6±0.4 mmol/L per hour in transplant recipients versus -0.12±0.3 mmol/L per hour in controls; Reduced osmoregulation performance occurs frequently in kidney transplant recipients and is an independent predictor of renal outcome.

Sections du résumé

BACKGROUND
Kidney transplant recipients have an impaired ability to dilute urine but seldom develop baseline hyponatremia before ESRD. Although hyponatremia is a risk factor for adverse events in CKD and in kidney transplant recipients, it remains unclear whether subtler alterations in osmoregulation performance are associated with outcome.
METHODS
We studied a single-center prospective cohort of 1258 kidney transplant recipients who underwent a water-loading test 3 months after transplant to determine osmoregulation performance. Measured GFR (mGFR) was performed at the same visit. A group of 164 healthy candidates for kidney donation served as controls. We further evaluated the association of osmoregulation performance with transplantation outcomes and subsequent kidney function.
RESULTS
Unlike controls, most kidney transplant recipients failed to maintain plasma sodium during water loading (plasma sodium slope of -0.6±0.4 mmol/L per hour in transplant recipients versus -0.12±0.3 mmol/L per hour in controls;
CONCLUSIONS
Reduced osmoregulation performance occurs frequently in kidney transplant recipients and is an independent predictor of renal outcome.

Identifiants

pubmed: 31217325
pii: ASN.2018121269
doi: 10.1681/ASN.2018121269
pmc: PMC6622417
doi:

Substances chimiques

Sodium 9NEZ333N27

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1282-1293

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 by the American Society of Nephrology.

Références

Life Sci. 1999;65(10):991-1004
pubmed: 10499867
N Engl J Med. 1999 Dec 2;341(23):1725-30
pubmed: 10580071
J Neurosci. 2000 Oct 15;20(20):7743-51
pubmed: 11027237
J Postgrad Med. 2003 Jan-Mar;49(1):69-71
pubmed: 12865574
Nephrol Dial Transplant. 2003 Sep;18(9):1755-63
pubmed: 12937221
Am J Physiol Renal Physiol. 2004 Dec;287(6):F1093-101
pubmed: 15522987
J Am Soc Nephrol. 2007 Dec;18(12):3056-9
pubmed: 18003769
J Am Soc Nephrol. 2008 Jun;19(6):1076-8
pubmed: 18337482
Nat Rev Neurosci. 2008 Jul;9(7):519-31
pubmed: 18509340
Kidney Int. 2009 Nov;76(9):960-7
pubmed: 19625993
Transplantation. 2009 Aug 27;88(4):561-7
pubmed: 19696640
Transplant Proc. 2009 Nov;41(9):3726-30
pubmed: 19917375
BMC Nephrol. 2010 Oct 05;11:26
pubmed: 20923561
Nephrol Dial Transplant. 2011 Jun;26(6):2042-4
pubmed: 21454354
Nephrol Dial Transplant. 2012 Mar;27(3):872-5
pubmed: 22379181
J Am Soc Nephrol. 2013 Apr;24(5):831-41
pubmed: 23539758
Endocrinol Metab Clin North Am. 2013 Jun;42(2):349-70
pubmed: 23702406
Am J Med. 2013 Oct;126(10 Suppl 1):S1-42
pubmed: 24074529
Transpl Int. 2014 Jan;27(1):19-27
pubmed: 24138291
Am J Kidney Dis. 2014 Feb;63(2):294-303
pubmed: 24239050
PLoS One. 2014 Feb 05;9(2):e87421
pubmed: 24505289
Am J Physiol Renal Physiol. 2014 May 1;306(9):F931-40
pubmed: 24598801
Am J Physiol Regul Integr Comp Physiol. 2014 Nov 1;307(9):R1092-100
pubmed: 25100078
J Clin Endocrinol Metab. 2014 Dec;99(12):4656-63
pubmed: 25202818
Methods Mol Biol. 2015;1266:29-53
pubmed: 25560066
Am J Kidney Dis. 2015 Jun;65(6):833-41
pubmed: 25600953
J Am Soc Nephrol. 2015 Dec;26(12):2978-87
pubmed: 25855780
Pediatr Transplant. 2015 Nov;19(7):698-703
pubmed: 26299753
Am J Nephrol. 2015;42(2):107-14
pubmed: 26346607
Cell Rep. 2015 Oct 6;13(1):23-30
pubmed: 26387947
J Endocrinol Invest. 2016 Sep;39(9):991-1001
pubmed: 27094044
PLoS One. 2016 May 23;11(5):e0156050
pubmed: 27214138
Am J Physiol Regul Integr Comp Physiol. 2016 Sep 1;311(3):R451-6
pubmed: 27335281
Hemodial Int. 2017 Jan;21(1):3-10
pubmed: 27350025
Neurosci Res. 2016 Dec;113:1-11
pubmed: 27521454
Kidney Res Clin Pract. 2016 Sep;35(3):142-6
pubmed: 27668156
Neuron. 2017 Jan 4;93(1):57-65
pubmed: 27989461
Curr Opin Nephrol Hypertens. 2017 Jul;26(4):311-318
pubmed: 28403013
Front Endocrinol (Lausanne). 2017 May 31;8:120
pubmed: 28620355
Clin Hypertens. 2017 Jun 13;23:13
pubmed: 28638629
J Intern Med. 2017 Oct;282(4):284-297
pubmed: 28649750
J Crit Care. 2017 Dec;42:54-58
pubmed: 28675827
J Am Soc Nephrol. 2017 Dec;28(12):3639-3646
pubmed: 28774998
N Engl J Med. 2017 Nov 16;377(20):1930-1942
pubmed: 29105594
Kidney Int Rep. 2017 Jan 23;2(3):410-419
pubmed: 29142968
Kidney Int Rep. 2017 May 18;2(5):881-892
pubmed: 29270495
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):366-374
pubmed: 29439092
JCI Insight. 2018 Jul 12;3(13):
pubmed: 29997293
Biomed Res Int. 2018 Jun 14;2018:2607928
pubmed: 30013980
Clin Kidney J. 2018 Aug;11(4):581-585
pubmed: 30094023
Neuron. 2019 Jan 2;101(1):60-75.e6
pubmed: 30503172
Clin Sci (Lond). 1988 Jun;74(6):599-606
pubmed: 3396297
Am J Physiol. 1983 Jun;244(6):E607-14
pubmed: 6407333
Recent Prog Horm Res. 1976;33:333-85
pubmed: 801194

Auteurs

Manal Mazloum (M)

Service de Department of Nephrology and Kidney Transplantation.
Medical Faculty, Paris University, Paris, France.

Jordan Jouffroy (J)

Medical Faculty, Paris University, Paris, France.
Department of Medical Informatics, and.

François Brazier (F)

Medical Faculty, Paris University, Paris, France.
Department of Physiology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Necker Enfants-Malades Research Institute, INSERM U1151, Paris, France; and.

Christophe Legendre (C)

Service de Department of Nephrology and Kidney Transplantation.
Medical Faculty, Paris University, Paris, France.
Necker Enfants-Malades Research Institute, INSERM U1151, Paris, France; and.

Antoine Neuraz (A)

Medical Faculty, Paris University, Paris, France.
Department of Medical Informatics, and.

Nicolas Garcelon (N)

Imagine Institute, Paris, France.

Dominique Prié (D)

Medical Faculty, Paris University, Paris, France.
Department of Physiology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Necker Enfants-Malades Research Institute, INSERM U1151, Paris, France; and.

Dany Anglicheau (D)

Service de Department of Nephrology and Kidney Transplantation.
Medical Faculty, Paris University, Paris, France.
Necker Enfants-Malades Research Institute, INSERM U1151, Paris, France; and.

Frank Bienaimé (F)

Medical Faculty, Paris University, Paris, France; frank.bienaime@inserm.fr.
Department of Physiology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Necker Enfants-Malades Research Institute, INSERM U1151, Paris, France; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH